| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 1036F |
|
1,306 |
1,248 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,264 |
2,134 |
$0.00 |
| 99000 |
|
181 |
170 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
63 |
62 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
941 |
912 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
37 |
30 |
$0.00 |
| 1006F |
|
464 |
448 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
515 |
502 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
30 |
27 |
$0.00 |
| G9459 |
Currently a tobacco non-user |
28 |
27 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
1,038 |
972 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,356 |
1,302 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,431 |
2,287 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
769 |
750 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
302 |
290 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
130 |
126 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
440 |
425 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
13 |
13 |
$0.00 |
| 4004F |
|
231 |
215 |
$0.00 |
| 80305 |
|
49 |
49 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
37 |
29 |
$0.00 |
| 99498 |
|
14 |
14 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
14 |
14 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16 |
16 |
$0.00 |
| 99497 |
|
14 |
14 |
$0.00 |